Ezetimibe Tablet is an inhibitor of intestinal cholesterol (and related phytosterol) absorption indicated as an adjunct to diet to:
Reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA reductase inhibitor (statin)
Reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with mixed hyperlipidemia in combination with fenofibrateReduce elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia (HoFH), in combination with atorvastatin or simvastatinReduce elevated sitosterol and campesterol in patients with homozygous sitosterolemia (phytosterolemia)
Limitations of Use The effect of Ezetimibe Tablet on cardiovascular morbidity and mortality has not been determined.
Ezetimibe Tablet has not been studied in Fredrickson Type I, III, IV, and V dyslipidemias.
